Gardiner Healthcare Acqui... (GDNR)
Gardiner Healthcare Acquisitions Statistics
Share Statistics
Gardiner Healthcare Acquisitions has - shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | - |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 888.53K |
| Failed to Deliver (FTD) Shares | 96 |
| FTD / Avg. Volume | 6.35% |
Short Selling Information
The latest short interest is 1.76K, so 0.05% of the outstanding shares have been sold short.
| Short Interest | 1.76K |
| Short % of Shares Out | 0.05% |
| Short % of Float | 0.15% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is 246.14 and the forward PE ratio is null. Gardiner Healthcare Acquisitions's PEG ratio is -0.37.
| PE Ratio | 246.14 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 5.87 |
| P/FCF Ratio | -82.2 |
| PEG Ratio | -0.37 |
Enterprise Valuation
Gardiner Healthcare Acquisitions has an Enterprise Value (EV) of 109.42M.
| EV / Sales | 0 |
| EV / EBITDA | -27.31 |
| EV / EBIT | -82.63 |
| EV / FCF | -82.63 |
Financial Position
The company has a current ratio of 0.19, with a Debt / Equity ratio of 0.03.
| Current Ratio | 0.19 |
| Quick Ratio | 0.19 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | -0.15 |
| Debt / FCF | -0.45 |
| Interest Coverage | 0.86 |
Financial Efficiency
Return on Equity is 2.39% and Return on Invested Capital is -13.92%.
| Return on Equity | 2.39% |
| Return on Assets | 2.15% |
| Return on Invested Capital | -13.92% |
| Revenue Per Employee | $- |
| Profits Per Employee | $- |
| Employee Count | undefined |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 223.16K |
| Effective Tax Rate | 33.54% |
Stock Price Statistics
The stock price has increased by 0% in the last 52 weeks. The beta is 0, so Gardiner Healthcare Acquisitions's price volatility has been lower than the market average.
| Beta | 0 |
| 52-Week Price Change | 0% |
| 50-Day Moving Average | 10.84 |
| 200-Day Moving Average | 10.71 |
| Relative Strength Index (RSI) | 57.13 |
| Average Volume (20 Days) | 1.51K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -4.01M |
| Net Income | 442.19K |
| EBITDA | -4.01M |
| EBIT | n/a |
| Earnings Per Share (EPS) | 0.21 |
Balance Sheet
The company has 15.81K in cash and 593.69K in debt, giving a net cash position of -577.88K.
| Cash & Cash Equivalents | 15.81K |
| Total Debt | 593.69K |
| Net Cash | -577.88K |
| Retained Earnings | -1.49M |
| Total Assets | 20.64M |
| Working Capital | -1.76M |
Cash Flow
In the last 12 months, operating cash flow was -1.32M and capital expenditures 0, giving a free cash flow of -1.32M.
| Operating Cash Flow | -1.32M |
| Capital Expenditures | 0 |
| Free Cash Flow | -1.32M |
| FCF Per Share | -0.12 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
GDNR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 0.41% |
| FCF Yield | -1.22% |
Analyst Forecast
Currently there are no analyst rating for GDNR.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 9.18 |
| Piotroski F-Score | 2 |